People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotech / Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oisin Biotechnologies, Inc. | — | Biotech / Pharma | Series A | $18.4M | $28.1M | 2021 |
| OncoSenX, Inc. | — | Other | Series A | $4.8M | $7.2M | 2021 |
Stephen Hilbert at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Hilbert on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Lewis | 2 | 6 |
| Gary Hudson | 2 | 3 |
| Matthew Scholz | 2 | 3 |
| Eric Garcia | 2 | 3 |
| David Gobel | 1 | 1 |
| Danjuma Quarless | 1 | 1 |
| Steve Hilbert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.